Jump to study

One nonrandomized study found that more hydroxychloroquine azithromycin patients tested negative for virus at days 3 and 6 but clinical outcomes were not reported.

One unblinded randomized trial showed no effect from hydroxychloroquine on viral or clinical outcomes. Without further evidence, hydroxychloroquine is not appropriate for patients with COVID-19 in primary care.